Also trades as: 1521.HK (HKSE) · $vol 0M

$0.17

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 60 · $354.9M mcap · 503M float · 0.011% daily turnover · Short 91% of daily vol

Revenue

$255M -1.9% ▼

5Y CAGR: +20.3%

Gross Profit

$70M -10.9% ▼

5Y CAGR: +13.2%

Operating Income

$9M -53.8% ▼

5Y CAGR: -9.8%

Net Income

$791K -92.7% ▼

5Y CAGR: -46.7%

EPS (Diluted)

$0.00 -92.3% ▼

5Y CAGR: -47.5%

EBITDA

$50M -12.8% ▼

5Y CAGR: +10.9%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$126M	$184M	$251M	$260M	$255M
YoY Growth	+24.6%	+46.1%	+36.5%	+3.5%	-1.9%
Cost of Revenue	$84M	$117M	$162M	$181M	$185M
Gross Profit	$41M	$66M	$89M	$78M	$70M
Gross Margin	33.0%	36.2%	35.6%	30.2%	27.4%
R&D Expenses	$2M	$2M	$4M	$6M	$6M
SG&A Expenses	$24M	$39M	$52M	$53M	$56M
Operating Expenses	$26M	$41M	$56M	$58M	$60M
Operating Income	$16M	$25M	$33M	$20M	$9M
Operating Margin	12.5%	13.7%	13.2%	7.8%	3.7%
Interest Expense	$2M	$3M	$4M	$7M	$10M
Income Before Tax	$20M	$25M	$36M	$15M	$3M
Tax Expense	$2M	$6M	$10M	$4M	$2M
Net Income	$17M	$18M	$26M	$11M	$791K
Net Margin	13.6%	10.0%	10.3%	4.2%	0.3%
EPS (Diluted)	$0.01	$0.01	$0.01	$0.01	$0.00
EBITDA	$34M	$52M	$70M	$57M	$50M
Shares Outstanding	2.08B	2.12B	2.08B	2.07B	2.03B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$132M	$128M	$132M	$128M	$127M	$127M	$130M	$148M
Cost of Revenue	$87M	$89M	$92M	$94M	$92M	$91M	$96M	$110M
Gross Profit	$45M	$39M	$39M	$35M	$35M	$35M	$34M	$38M
Gross Margin	34.2%	30.4%	30.0%	27.1%	27.7%	27.9%	26.0%	25.6%
R&D Expenses	$2M	$3M	$3M	$3M	$3M	$2M	$2M	$3M
SG&A Expenses	$27M	$27M	$25M	$29M	$27M	$26M	$24M	$22M
Operating Expenses	$29M	$30M	$28M	$32M	$29M	$28M	$27M	$25M
Operating Income	$16M	$8M	$11M	$3M	$6M	$7M	$7M	$13M
Operating Margin	12.1%	6.6%	8.5%	2.1%	4.4%	5.7%	5.6%	8.8%
Interest Expense	$3M	$3M	$4M	$4M	$5M	$4M	$3M	$3M
Income Before Tax	$18M	$8M	$7M	$397K	$2M	$5M	$6M	$9M
Tax Expense	$5M	$3M	$1M	$697K	$1M	$2M	$3M	$3M
Net Income	$13M	$5M	$6M	-$117K	$910K	$3M	$4M	$7M
Net Margin	9.7%	3.6%	4.7%	-0.1%	0.7%	2.3%	3.0%	4.6%
EPS (Diluted)	$0.01	$0.00	$0.00	$-0.00	$0.00	$0.00	$0.00	$0.00
EBITDA	$37M	$28M	$29M	$17M	$26M	$21M	$25M	$32M
Shares Outstanding	2.06B	2.07B	2.07B	2.03B	2.03B	2.03B	2.02B	2.03B

FGHQF OTC